1540-nm fractional erbium: Glass laser is a safe and effective modality for nonablative facial rejuvenation.
Erbium:glass laser
facial rejuvenation
nonablative laser
rhytids
wrinkles
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
revised:
11
01
2021
received:
19
12
2020
accepted:
18
01
2021
pubmed:
2
2
2021
medline:
25
5
2021
entrez:
1
2
2021
Statut:
ppublish
Résumé
Laser treatments for facial rejuvenation are common, with ablative modalities being of more common use for this indication. Efficient nonablative modalities are of rising demand. Our aim was to determine the safety and efficacy of high-fluence, nonablative 1540-nm fractional Erbium:glass laser for facial rejuvenation. A retrospective study of patients treated with 3-4 treatments using the 1540-nm fractional Erbium:glass laser for facial rejuvenation, using 2500-3000 mJ/stacked pulses (51-61 mJ per pixel). Patients were followed-up for 3 months following their last treatment. Before and after photos were independently blindly evaluated by 2 dermatologists, who graded them using a scale from 0 (exacerbation) to 4 (76%-100% improvement) for 2 different facial regions (frontal face region and lateral canthal region). Pain perception and adverse effects as well as patient satisfaction were documented throughout the study. Sixteen patients completed both treatment and follow-up period. At the 3-months posttreatment follow-up visit, moderate-to-significant improvement in rhytids appearance (mean grade of improvement: 2.93 for frontal face and 3 for lateral canthal region) was observed. Patients' satisfaction was high (4.25). Patients reported mild and transient erythema posttreatment with no other adverse effects. The high-fluence 1540-nm fractional Erbium:glass laser is a safe and effective nonablative modality for facial rejuvenation.
Sections du résumé
BACKGROUND
BACKGROUND
Laser treatments for facial rejuvenation are common, with ablative modalities being of more common use for this indication. Efficient nonablative modalities are of rising demand.
AIM
OBJECTIVE
Our aim was to determine the safety and efficacy of high-fluence, nonablative 1540-nm fractional Erbium:glass laser for facial rejuvenation.
PATIENTS AND METHODS
METHODS
A retrospective study of patients treated with 3-4 treatments using the 1540-nm fractional Erbium:glass laser for facial rejuvenation, using 2500-3000 mJ/stacked pulses (51-61 mJ per pixel). Patients were followed-up for 3 months following their last treatment. Before and after photos were independently blindly evaluated by 2 dermatologists, who graded them using a scale from 0 (exacerbation) to 4 (76%-100% improvement) for 2 different facial regions (frontal face region and lateral canthal region). Pain perception and adverse effects as well as patient satisfaction were documented throughout the study.
RESULTS
RESULTS
Sixteen patients completed both treatment and follow-up period. At the 3-months posttreatment follow-up visit, moderate-to-significant improvement in rhytids appearance (mean grade of improvement: 2.93 for frontal face and 3 for lateral canthal region) was observed. Patients' satisfaction was high (4.25). Patients reported mild and transient erythema posttreatment with no other adverse effects.
CONCLUSION
CONCLUSIONS
The high-fluence 1540-nm fractional Erbium:glass laser is a safe and effective nonablative modality for facial rejuvenation.
Substances chimiques
Erbium
77B218D3YE
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1679-1683Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Kohl E, Steinbauer J, Landthaler M, Szeimies RM. Skin ageing. J Eur Acad Dermatol Venereol. 2011;25(8):873-884.
Khavkin J, Ellis DA. Aging skin: histology, physiology, and pathology. Facial Plast Surg Clin North Am. 2011;19(2):229-234.
Katsambas AD, Katoulis AC. Topical retinoids in the treatment of aging of the skin. Adv Exp Med Biol. 1999;455:477-482.
Pathak A, Mohan R, Rohrich RJ. Chemical peels: role of chemical peels in facial rejuvenation today. Plast Reconstr Surg. 2020;145(1):58e-66e.
Mckee D, Remington K, Swift A, Lambros V, Comstock J, Lalonde D. Effective rejuvenation with hyaluronic acid fillers: current advanced concepts. Plast Reconstr Surg. 2019;143(6):1277e-1289e.
Cohn JE, Greco TM. Advanced techniques for the use of neurotoxins in non-surgical facial rejuvenation. Aesthetic Plast Surg. 2020;44:1788.
Barikbin B, Akbari Z, Vafaee R, Razzaghi Z. The efficacy of IPL in periorbital skin rejuvenation: an open-label study. J Lasers Med Sci. 2019;10(Suppl:1):S64-S67.
Gold MH, Biron J, Wilson A. Improvement of skin texture and wrinkles using radiofrequency ultra-thin electrode technology. J Cosmet Dermatol. 2020;19(2):388-392.
Cohen JL, Ross EV. Combined fractional ablative and nonablative laser resurfacing treatment: a split-face comparative study. J Drugs Dermatol. 2013;12(2):175-178.
Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol. 2008;58(5):719-37.
Brightman LA, Brauer JA, Anolik R, et al. Ablative and fractional ablative lasers. Dermatol Clin. 2009;27(4):479-89.
Metelitsa AI, Alster TS. Fractionated laser skin resurfacing treatment complications: a review. Dermatol Surg. 2010;36(3):299-306.
Tierney EP, Eisen RF, Hanke CW. Fractionated CO2 laser skin rejuvenation. Dermatol Ther. 2011;24(1):41-53.
Lipozenčić J, Mokos ZB. Will nonablative rejuvenation replace ablative lasers? Facts and controversies. Clin Dermatol. 2013;31(6):718-724.
Al Anwer MH. Fractional versus ablative erbium:yttrium-aluminum-garnet laser resurfacing for facial rejuvenation: an objective evaluation. J Am Acad Dermatol. 2013;68(1):103-112.
Heidari Beigvand H, Razzaghi M, Rostami-Nejad M, et al. Assessment of laser effects on skin rejuvenation. J Lasers Med Sci. 2020;11(2):212-219.
Borges J, Araújo L, Cuzzi T, Martinez L, Gonzales Y, Manela-Azulay M. Fractional laser resurfacing treats photoaging by promoting neocollegenesis and cutaneous edema. J Clin Aesthet Dermatol. 2020;13(1):22-27.
Politi Y, Levi A, Lapidoth M. Integrated cooling-vacuum-assisted non-fractional 1540 nm erbium: glass laser is effective in treating acne scars. J Drugs Dermatol. 2016;15(11):1359-1363.
Politi Y, Levi A, Enk CD, Lapidoth M. Integrated cooling-vacuum-assisted 1540-nm erbium:glass laser is effective in treating mild-to-moderate acne vulgaris. Lasers Med Sci. 2015;30(9):2389-2393.
Tidwell WJ, Owen CE, Kulp-Shorten C, Maity A, McCall M, Brown TS. Fractionated Er:YAG laser versus fully ablative Er:YAG laser for scar revision: Results of a split scar, double blinded, prospective trial. Lasers Surg Med. 2016;48(9):837-843.
Al-Dhalimi M, Jaber A. Treatment of atrophic facial acne scars with fractional Er: Yag laser. J Cosmet Laser Ther. 2015;17(4):184-188.
Akaishi S, Koike S, Dohi T, Kobe K, Hyakusoku H, Ogawa R. Nd:YAG laser treatment of keloids and hypertrophic scars. Eplasty. 2012;12:e1.
Carniol PJ, Hamilton MM, Carniol ET. Current status of fractional laser resurfacing. JAMA Facial Plast Surg. 2015;17(5):360-366.
de Sica RC, Rodrigues CJ, Maria DA, Cucé LC. Study of 1550nm Erbium Glass Laser Fractional non-ablative treatment of photoaging: Comparative clinical effects, histopathology, electron microscopy and immunohistochemistry. J Cosmet Laser Ther. 2016;25:1-36.